nach oben

Inflammation

Erschienen in:

01.08.2012

Association of MicroRNA-146a with Autoimmune Diseases

verfasst von: Wang-Dong Xu, Man-Man Lu, Hai-Feng Pan, Dong-Qing Ye

Erschienen in: Inflammation | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs (miRNAs) are a group of approximately 20–22-nucleotide-long non-coding RNAs that repress target gene expression through mRNA degradation and translation inhibition. MiRNA (miR)-146a, located in the second exon of the LOC285628 gene on human chromosome 5, is a negative regulator in immune and inflammatory responses. Studies have indicated that miR-146a is associated with the pathogenesis of several autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and Sjögren’s syndrome. In this review, emphasis will be laid on the recent progress in the functional roles of miR-146a in these autoimmune diseases.

Luo, X., L.M. Tsai, N. Shen, and D. Yu. 2010. Evidence for microRNA-mediated regulation in rheumatic diseases. Annals of the Rheumatic Diseases 69(Suppl I): i30–i36.PubMedCrossRef

Taganov, K.D., M.P. Boldin, K.J. Chang, and D. Baltimore. 2006. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 103: 12481–12486.

Vyse, T.J., and B.L. Kotzin. 1996. Genetic basis of systemic lupus erythematosus. Current Opinion in Immunology 8: 843–851.PubMedCrossRef

Tang, Y., X. Luo, H. Cui, X. Ni, M. Yuan, Y. Guo, X. Huang, H. Zhou, N. de Vries, P.P. Tak, S. Chen, and N. Shen. 2009. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis & Rheumatism 60: 1065–1075.CrossRef

Vollmer, J., S. Tluk, C. Schmitz, S. Hamm, M. Jurk, A. Forsbach, S. Akira, K.M. Kelly, W.H. Reeves, S. Bauer, and A.M. Krieg. 2005. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. The Journal of Experimental Medicine 202: 1575–1585.PubMedCrossRef

Means, T.K., E. Latz, F. Hayashi, et al. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. Journal of Clinical Investigation 115: 407–417.PubMed

Barrat, F.J., T. Meeker, J. Gregorio, J.H. Chan, S. Uematsu, S. Akira, B. Chang, O. Duramad, and R.L. Coffman. 2005. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. The Journal of Experimental Medicine 202: 1131–1139.PubMedCrossRef

Uematsu, S., S. Sato, M. Yamamoto, T. Hirotani, H. Kato, F. Takeshita, M. Matsuda, C. Coban, K.J. Ishii, T. Kawai, O. Takeuchi, and S. Akira. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. The Journal of Experimental Medicine 201: 915–923.PubMedCrossRef

Kawai, T., S. Sato, K.J. Ishii, C. Coban, H. Hemmi, M. Yamamoto, K. Terai, M. Matsuda, J. Inoue, S. Uematsu, O. Takeuchi, and S. Akira. 2004. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunology 5: 1061–1068.PubMedCrossRef

10.

Schoenemeyer, A., B.J. Barnes, M.E. Mancl, E. Latz, N. Goutagny, P.M. Pitha, K.A. Fitzgerald, and D.T. Golenbock. 2005. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. Journal of Biological Chemistry 280: 17005–17012.PubMedCrossRef

11.

Li, Q.J., J. Chau, P.J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, L.O. Klein, M.M. Davis, and C.Z. Chen. 2007. miR-181a is an intrinsic modulator of t cell sensitivity and selection. Cell 129: 147–161.PubMedCrossRef

12.

Platanias, L.C. 2005. Mechanisms of type I and type II interferon mediated signalling. Nature Reviews Immunology 5: 375–386.PubMedCrossRef

13.

Dai, R., Y. Zhang, D. Khan, B. Heid, D. Caudell, O. Crasta, and S.A. Ahmed. 2010. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 5: e14302.PubMedCrossRef

14.

Pan, Q., X. Luo, and N. Chegini. 2010. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Molecular Human Reproduction 16: 215–227.PubMedCrossRef

15.

Lu, J., B.C. Kwan, F.M. Lai, L.S. Tam, E.K. Li, K.M. Chow, G. Wang, P.K. Li, and C.C. Szeto. 2012. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton, Vic.). doi:10.1111/j.1440-1797.2012.01573.x.

16.

Pauley, K.M., S. Cha, and E.K. Chan. 2009. MicroRNA in autoimmunity and autoimmune diseases. Journal of Autoimmunity 32: 189–194.PubMedCrossRef

17.

Lu, L.F., M.P. Boldin, A. Chaudhry, L.L. Lin, K.D. Taganov, T. Hanada, A. Yoshimura, D. Baltimore, and A.Y. Rudensky. 2010. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142: 914–929.PubMedCrossRef

18.

Luo, X., W. Yang, D.Q. Ye, H. Cui, Y. Zhang, N. Hirankarn, X. Qian, Y. Tang, Y.L. Lau, N. de Vries, P.P. Tak, B.P. Tsao, and N. Shen. 2011. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 7: e1002128.PubMedCrossRef

19.

Zhang, J., B. Yang, B. Ying, D. Li, Y. Shi, X. Song, B. Cai, Z. Huang, Y. Wu, and L. Wang. 2011. Association of pre-microRNAs genetic variants with susceptibility in systemic lupus erythematosus. Molecular Biology Reports 38: 1463–1468.PubMedCrossRef

20.

Löfgren, S.E., Frostegård, J., Truedsson, L., Pons-Estel, B.A., D'Alfonso, S., Witte, T., Lauwerys, B.R., Endreffy, E., Kovács, L., Vasconcelos, C., Martins, da. Silva. B., Kozyrev, S.V., Alarcón-Riquelme, M.E. 2012. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes and Immunity doi:10.1038/gene.2011.84.

21.

Morgan, A.W., J.I. Robinson, P.G. Conaghan, S.G. Martin, E.M. Hensor, M.D. Morgan, L. Steiner, H.A. Erlich, H.C. Gooi, A. Barton, J. Worthington, and P. Emery. 2010. Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception Cohort. Arthritis Research & Therapy 12: R57.CrossRef

22.

Nakasa, T., H. Shibuya, Y. Nagata, T. Niimoto, and M. Ochi. 2011. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis and Rheumatism 63: 1582–1590.PubMedCrossRef

23.

Murata, K., H. Yoshitomi, S. Tanida, M. Ishikawa, K. Nishitani, H. Ito, and T. Nakamura. 2010. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Research & Therapy 12: R86.CrossRef

24.

Nakasa, T., S. Miyaki, A. Okubo, M. Hashimoto, K. Nishida, M. Ochi, and H. Asahara. 2008. Expression of MicroRNA-146 in rheumatoid arthritis synovial tissue. Arthritis and Rheumatism 58: 1284–1292.PubMedCrossRef

25.

Franzoso, G., L. Carlson, L. Xing, L. Poljak, E.W. Shores, K.D. Brown, A. Leonardi, T. Tran, B.F. Boyce, and U. Siebenlist. 1997. Requirement for NF-kB in osteoclast and B-cell development. Genes & Development 11: 3482–3496.CrossRef

26.

Clohisy, J.C., B.C. Roy, C. Biondo, E. Frazier, D. Willis, S.L. Teitelbaum, and Y. Abu-Amer. 2003. Direct inhibition of NF-κB blocks bone erosion associated with inflammatory arthritis. Journal of Immunology 171: 5547–5553.

27.

Pauley, K.M., M. Satoh, A.L. Chan, M.R. Bubb, W.H. Reeves, and E.K. Chan. 2008. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Research & Therapy 10: R101.CrossRef

28.

Li, J., Y. Wan, Q. Guo, L. Zou, J. Zhang, Y. Fang, J. Zhang, J. Zhang, X. Fu, H. Liu, L. Lu, and Y. Wu. 2010. Research article altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Research & Therapy 12: R81.CrossRef

29.

Ryu, S.W., S.K. Chae, K.J. Lee, and E. Kim. 1999. Identification and characterization of human Fas associated aactor 1, hFAF1. Biochemical and Biophysical Research Communications 262: 388–394.PubMedCrossRef

30.

Ryu, S.W., and E. Kim. 2001. Apoptosis Induced by human Fas-associated aactor 1, hFAF1, requires its ubiquitin homologous domain, but not the Fas-binding domain. Biochemical and Biophysical Research Communications 286: 1027–1032.PubMedCrossRef

31.

Park, M.Y., H.D. Jang, S.Y. Lee, K.J. Lee, and E. Kim. 2004. Fas-associated factor-1 Inhibits nuclear factor-κB (NF-κB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-κB. Journal of Biological Chemistry 279: 1544–1549.

32.

Curtale, G., F. Citarella, C. Carissimi, M. Goldoni, N. Carucci, V. Fulci, D. Franceschini, F. Meloni, V. Barnaba, and G. Macino. 2010. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115: 265–273.PubMedCrossRef

33.

Ryu, S.W., S.J. Lee, M.Y. Park, J.I. Jun, Y.K. Jung, and E. Kim. 2003. Fas-associated factor 1, FAF1, is a member of fas death-inducing signaling complex. Journal of Biological Chemistry 178: 24003–24010.CrossRef

34.

Niimoto, T., T. Nakasa, M. Ishikawa, A. Okuhara, B. Izumi, M. Deie, O. Suzuki, N. Adachi, and M. Ochi. 2010. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskeletal Disorders 11: 209.PubMedCrossRef

35.

Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nature Reviews Immunology 7: 454–465.PubMedCrossRef

36.

Lu, L.F., T.H. Thai, D.P. Calado, A. Chaudhry, M. Kubo, K. Tanaka, G.B. Loeb, H. Lee, A. Yoshimura, K. Rajewsky, and A.Y. Rudensky. 2009. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells through targeting SOCS1. Immunity 30: 80–91.PubMedCrossRef

37.

Chatzikyriakidou, A., P.V. Voulgari, I. Georgiou, and A.A. Drosos. 2010. A polymorphism in the 3′-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint, Bone, Spine 77: 411–413.PubMedCrossRef

38.

Yang, B., J.L. Zhang, Y.Y. Shi, D.D. Li, J. Chen, Z.C. Huang, B. Cai, X.B. Song, L.X. Li, B.W. Ying, and L.L. Wang. 2011. Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population. Molecular Biology Reports 38: 4913–4919.PubMedCrossRef

39.

Pauley, K.M., C.M. Stewart, A.E. Gauna, L.C. Dupre, R. Kuklani, A.L. Chan, B.A. Pauley, W.H. Reeves, E.K. Chan, and S. Cha. 2011. Altered miR-146a expression in Sjögren’s syndrome and its functional role in innate immunity. European Journal of Immunology 41: 2029–2039.PubMedCrossRef

40.

Bombardieri, M., F. Barone, V. Pittoni, C. Alessandri, P. Conigliaro, M.C. Blades, R. Priori, I.B. McInnes, G. Valesini, and C. Pitzalis. 2004. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Research & Therapy 6: R447–R456.CrossRef

41.

Eriksson, P., C. Andersson, C. Ekerfelt, J. Ernerudh, and T. Skogh. 2004. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjögren’s syndrome, rheumatoid arthritis and healthy controls. Clinical and Experimental Immunology 137: 617–620.PubMedCrossRef

42.

Szodoray, P., P. Alex, J.G. Brun, M. Centola, and R. Jonsson. 2004. Circulating cytokines in primary Sjögren’s syndrome determined by a multiplex cytokine array system. Scandinavian Journal of Immunology 59: 592–599.PubMedCrossRef

43.

Yamano, S., J.C. Atkinson, B.J. Baum, and P.C. Fox. 1999. Salivary gland cytokine expression in NOD and normal BALB/c Mice. Clinical Immunology 92: 265–275.PubMedCrossRef

44.

Zilahi, E., T. Tarr, G. Papp, Z. Griger, S. Sipka, and M. Zeher. 2011. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren’s syndrome. Immunology Letters. doi:10.1016/j.imlet.2011.09.006.

Titel: Association of MicroRNA-146a with Autoimmune Diseases
verfasst von: Wang-Dong Xu
Man-Man Lu
Hai-Feng Pan
Dong-Qing Ye
Publikationsdatum: 01.08.2012
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 4/2012
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-012-9467-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Association of MicroRNA-146a with Autoimmune Diseases

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Interleukin-1 Beta Increases Activity of Human Endothelial Progenitor Cells: Involvement of PI3K-Akt Signaling Pathway

Expression of Complement Components and Regulators by Different Subtypes of Bone Marrow-Derived Macrophages

Effect of Porphyromonas gingivalis and Lactobacillus acidophilus on Secretion of IL1B, IL6, and IL8 by Gingival Epithelial Cells

Comparison of Quantiferon Test with Tuberculin Skin Test for the Detection of Tuberculosis Infection in Children

Oxidized LDLs Inhibit TLR-induced IL-10 Production by Monocytes: A New Aspect of Pathogen-Accelerated Atherosclerosis

Apigenin Inhibits the Expression of IL-6, IL-8, and ICAM-1 in DEHP-Stimulated Human Umbilical Vein Endothelial Cells and In Vivo

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin